Evandro de Azambuja

Institut Jules Bordet

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Cancer Biology Cancer Biology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (15)

Gabor Rubovszky

head

National Institute of Oncology

HUNGARY

View details

Christos Sotiriou

Université libre de Bruxelles

BELGIUM

View details

Kok Haw Jonathan Lim

The University of Manchester

UNITED KINGDOM

View details

Mariana Brandão

Institut Jules Bordet

BELGIUM

View details

Sara Pizzamiglio

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Maria Margarete Karsten

GERMANY

View details

Caterina MARCHIO'

Associate Professor of Pathology

University of Turin

ITALY

View details

Elisa Agostinetto

Institut Jules Bordet

BELGIUM

View details

Lee Schwartzberg

Chief

UNITED STATES

View details

Claire Hardy

University of Lancaster

UNITED KINGDOM

View details

Matteo Lambertini

University of Genova

ITALY

View details

C. Florin Pop

Université libre de Bruxelles

BELGIUM

View details

Paolo Nuciforo

Head

Vall d´Hebron Institut d´Oncologia

SPAIN

View details

Alex De Caluwe

Université libre de Bruxelles (ULB)

BELGIUM

View details

Ahmad Awada

Université libre de Bruxelles (ULB)

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Evandro de Azambuja

Research Interests

Explore related searches

Contact this professor

Articles (21)

Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study

Response to Venkataraman and Mokbel

Extended adjuvant endocrine therapy in early breast cancer: finding the individual balance

Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)

Response to letter “re: Surgery of the primary tumor in patients with de novo metastatic breast cancer: A nationwide population–based retrospective cohort study in Belgium and the National Cancer Database (NCDB)”

Going beyond the 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review

ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology

Tumour heterogeneity in molecular imaging for breast cancer

Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely?

Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysis

Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer

Medical Oncology Education in Europe: Equipping Medical Oncologists to Provide the Best Care for Patients with Cancer

HER2-Low Breast Cancer: Where Are We?

Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer

Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel

Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer

Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis

Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer

Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis

OncoAlert Round Table Discussions: The Global COVID-19 Experience

Collaborators (15)

Gabor Rubovszky

Christos Sotiriou

Kok Haw Jonathan Lim

Mariana Brandão

Sara Pizzamiglio

Maria Margarete Karsten

Caterina MARCHIO'

Elisa Agostinetto

Lee Schwartzberg

Claire Hardy

Matteo Lambertini

C. Florin Pop

Paolo Nuciforo

Alex De Caluwe

Ahmad Awada

Make your next move.